Skip to main content
Fig. 3 | Cellular & Molecular Biology Letters

Fig. 3

From: Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1

Fig. 3

The effects of silibinin on NSCLC cell behaviors and the expressions of RHBDD1 and EMT markers. A549 cells were treated with silibinin (10, 20 and 40 μM) or vehicle (DMSO) for 24 h. a Cell proliferation was analyzed using the CCK-8 assay. b Transwell migration and invasion assays were performed in A549 cells. c The protein expressions of RHBDD1, E-cadherin, N-cadherin and vimentin were determined using western blotting. Data are expressed as means ± standard deviation (SD). *p < 0.05, **p < 0.01, ***p < 0.001, compared with DMSO control

Back to article page

Cellular & Molecular Biology Letters

ISSN: 1689-1392

Contact us